Is the NHS ready for new Alzheimer's disease treatments?
New effective treatments for Alzheimer's disease have eluded researchers for many years, but promising pharmacotherapies may at last be approaching clinical approval. This article examines some of these new treatments, their modes of action and the practicalities of implementation once they reach th...
| Publicado en: | Prescriber Vol. 34; no. 7; pp. 15 - 19 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
Wiley-Blackwell
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164961430&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 164961430 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09596682 BAEE jtl: Prescriber issn: 09596682 maglogo: Y pubinfo: dt: Jul2023 vid: 34 iid: 7 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 164961430 164961430 164961430 10.1002/psb.2078 164961430 ppf: 15 ppct: 4 formats: tig: atl: Is the NHS ready for new Alzheimer's disease treatments? aug: au: Greener, Mark affil: Mark Greener is a freelance medical writer and journalist sug: subj: National Health Programs Alzheimer's Disease Therapy Alzheimer's Disease Prevention and Control Amyloid beta-Peptides Metabolism Early Diagnosis Amyloids Antibodies, Monoclonal Drug Development Implementation Science ab: New effective treatments for Alzheimer's disease have eluded researchers for many years, but promising pharmacotherapies may at last be approaching clinical approval. This article examines some of these new treatments, their modes of action and the practicalities of implementation once they reach the market. pubtype: Academic Journal doctype: pictorial Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|